help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugawara, J.
Right arrow Articles by Giudice, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugawara, J.
Right arrow Articles by Giudice, L. C.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 10 3821-3827
Copyright © 2000 by The Endocrine Society


Original Studies

Regulation of Insulin-Like Growth Factor-Binding Protein 1 by Hypoxia and 3',5'-Cyclic Adenosine Monophosphate Is Additive in HepG2 Cells1

Junichi Sugawara, Salli I. Tazuke, Lii F-Suen, David R. Powell, Fiona Kaper, Amato J. Giaccia and Linda C. Giudice

Departments of Gynecology and Obstetrics (J.S., S.I.T., L.F.-S., L.C.G.) and Radiation Oncology (F.K., A.J.G.), Stanford University Medical School, Stanford, California 94305-5317; and Department of Pediatrics (D.R.P.), Baylor College of Medicine, Houston, Texas 77030

Address correspondence and requests for reprints to: Linda C. Giudice, M.D., Ph.D., Department of Gynecology and Obstetrics, Stanford University Medical Center, Room HH-333, Stanford, California 94305-5317. E-mail: giudice{at}stanford.edu

Insulin-like growth factor-binding protein 1 (IGFBP-1) is important in regulating minute-to-minute IGF bioavailability in the circulation and is primarily an inhibitor of IGF action systemically and in most cellular systems. Understanding regulation of IGFBP-1 is, thus, important in understanding regulation of IGF actions. The IGFBP-1 promoter contains a cAMP response element, and cAMP stimulates IGFBP-1 gene expression at the transcriptional level. Recently, we have found three consensus sequences for the hypoxia response element in intron 1 of the IGFBP-1 gene. Herein, we have investigated the effects of hypoxia and a cAMP analog, 8-bromoadenosine-3',5'-cyclic monophosphate (8-Br-cAMP), on IGFBP-1 expression in HepG2 cells, a model system for IGFBP-1 gene regulation. HepG2 cells were exposed to normoxia (20% pO2) or hypoxia (2% pO2) for 24 h in the absence or presence of 8-Br-cAMP (0.1, 0.5, and 1 mM). Western ligand blotting revealed IGFBP-1 as the predominant IGFBP in HepG2-conditioned media, which increased in a dose-dependent manner after incubation with 8-Br-cAMP in normoxia and hypoxia (3-fold and 7-fold at 1 mM, respectively). Under hypoxic, compared with normoxic, conditions, IGFBP-1 protein and messenger RNA (mRNA) levels increased ~10-fold and 20-fold, respectively. In normoxia, 8-Br-cAMP stimulated IGFBP-1 protein and mRNA levels in a dose-dependent manner (7-fold and 10-fold at 1 mM). Hypoxia and 8-Br-cAMP showed additive stimulatory effects on IGFBP-1 protein and mRNA levels (35-fold and 50-fold at 1 mM) that were time and dose dependent. Primary transcripts of IGFBP-1 mRNA were increased concordantly with IGFBP-1 mRNA. The half-life of the IGFBP-1 mRNA was markedly increased (~6-fold) by hypoxia, and cAMP minimally enhanced this effect. These results demonstrate that hypoxia and compounds that increase intracellular cAMP additively regulate IGFBP-1 gene expression by transcriptional and posttranscriptional mechanisms. Regulation of IGFBP-1 mRNA and protein by cAMP and hypoxia may be important for understanding the physiologic and pathophysiologic roles of IGFBP-1.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X.-Q. Chen, S.-J. Wang, J.-Z. Du, and X.-C. Chen
Diversities in hepatic HIF-1, IGF-I/IGFBP-1, LDH/ICD, and their mRNA expressions induced by CoCl2 in Qinghai-Tibetan plateau mammals and sea level mice
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R516 - R526.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. H. Stephens, P. McElduff, A. H. Heald, J. P. New, J. Worthington, W. E. Ollier, and J. M. Gibson
Polymorphisms in IGF-Binding Protein 1 Are Associated With Impaired Renal Function in Type 2 Diabetes
Diabetes, December 1, 2005; 54(12): 3547 - 3553.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
V. Roelfsema, A. J. Gunn, B. H. Breier, J. S. Quaedackers, and L. Bennet
The Effect of Mild Hypothermia on Insulin-like Growth Factors After Severe Asphyxia in the Preterm Fetal Sheep
Reproductive Sciences, May 1, 2005; 12(4): 232 - 237.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Mesotten, P. J. D. Delhanty, F. Vanderhoydonc, K. V. Hardman, F. Weekers, R. C. Baxter, and G. van den Berghe
Regulation of Insulin-Like Growth Factor Binding Protein-1 during Protracted Critical Illness
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5516 - 5523.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Bajoria, S. R. Sooranna, S. Ward, and M. Hancock
Placenta as a Link between Amino Acids, Insulin-IGF Axis, and Low Birth Weight: Evidence from Twin Studies
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 308 - 315.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society